Found: 30
Select item for more details and to access through your institution.
Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT).
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 6, p. 1473, doi. 10.1093/cid/ciae043
- By:
- Publication type:
- Article
Applying Desirability of Outcome Ranking End Point to Randomized Trial of Sulopenem for the Treatment of Complicated Urinary Tract Infections.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 12, p. 2213, doi. 10.1093/cid/ciad149
- By:
- Publication type:
- Article
Efficacy and Safety of Adintrevimab (ADG20) for the Treatment of High-Risk Ambulatory Patients With Mild or Moderate Coronavirus Disease 2019: Results From a Phase 2/3, Randomized, Placebo-Controlled Trial (STAMP) Conducted During Delta Predominance and Early Emergence of Omicron
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 6, p. 1, doi. 10.1093/ofid/ofad279
- By:
- Publication type:
- Article
Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 1, p. 66, doi. 10.1093/cid/ciac738
- By:
- Publication type:
- Article
Sulopenem for the Treatment of Complicated Urinary Tract Infections Including Pyelonephritis: A Phase 3, Randomized Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 1, p. 78, doi. 10.1093/cid/ciac704
- By:
- Publication type:
- Article
Lefamulin in Patients with Community-Acquired Bacterial Pneumonia Caused by Atypical Respiratory Pathogens: Pooled Results from Two Phase 3 Trials.
- Published in:
- Antibiotics (2079-6382), 2021, v. 10, n. 12, p. 1489, doi. 10.3390/antibiotics10121489
- By:
- Publication type:
- Article
Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 11, p. e3647, doi. 10.1093/cid/ciaa1380
- By:
- Publication type:
- Article
Efficacy of Omadacycline Versus Moxifloxacin in the Treatment of Community-Acquired Bacterial Pneumonia by Disease Severity: Results From the OPTIC Study.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 6, p. 1, doi. 10.1093/ofid/ofab135
- By:
- Publication type:
- Article
Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 6, p. 1, doi. 10.1093/ofid/ofab136
- By:
- Publication type:
- Article
Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Fosfomycin for Injection (ZTI-01) Versus Piperacillin-tazobactam for the Treatment of Complicated Urinary Tract Infection Including Acute Pyelonephritis: ZEUS, A Phase 2/3 Randomized Trial.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2045, doi. 10.1093/cid/ciz181
- By:
- Publication type:
- Article
Oral Lefamulin vs Moxifloxacin for Early Clinical Response Among Adults With Community-Acquired Bacterial Pneumonia: The LEAP 2 Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
110. Clinical Outcomes of Patients with Secondary Bacteremia in the Omadacycline Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S86, doi. 10.1093/ofid/ofz360.185
- By:
- Publication type:
- Article
663. Efficacy and Safety of Lefamulin (LEF) vs. Moxifloxacin (MOX) for Legionella pneumophila (LP) in Patients with Community-Acquired Bacterial Pneumonia (CABP): Pooled Results From the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Phase 3 Clinical Trials
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S303, doi. 10.1093/ofid/ofz360.731
- By:
- Publication type:
- Article
664. Efficacy in Adults With Moderate to Severe Community-Acquired Bacterial Pneumonia (CABP) and Pneumonia Outcomes Research Team (PORT) Risk Class III to V: Results of a Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Outcomes
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S304, doi. 10.1093/ofid/ofz360.732
- By:
- Publication type:
- Article
684. Cardiac Safety in Adults with Community-Acquired Bacterial Pneumonia (CABP) Treated with Lefamulin (LEF) or Moxifloxacin (MOX): Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Results.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S311, doi. 10.1093/ofid/ofz360.752
- By:
- Publication type:
- Article
699. Hepatobiliary Safety in Adults With Community-Acquired Bacterial Pneumonia (CABP) Treated With Lefamulin (LEF) or Moxifloxacin (MOX): Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Results.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S316, doi. 10.1093/ofid/ofz360.767
- By:
- Publication type:
- Article
717. Lefamulin (LEF) vs. Moxifloxacin (MOX) in Patients With Community-Acquired Bacterial Pneumonia (CABP) at Risk for Poor Efficacy or Safety Outcomes: Pooled Subgroup Analyses From the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Phase 3 Noninferiority Clinical Trials
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S322, doi. 10.1093/ofid/ofz360.785
- By:
- Publication type:
- Article
720. Efficacy of Fosfomycin for Injection (FOS) vs. Piperacillin–Tazobactam (PIP-TAZ) in Adults with Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP): ZEUS Study Outcomes in Patients With Reduced Study Drug Susceptibility.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S324, doi. 10.1093/ofid/ofz360.788
- By:
- Publication type:
- Article
2233. Efficacy and Symptom Resolution by Visit in Adults With Community-Acquired Bacterial Pneumonia (CABP) Treated With Lefamulin (LEF) or Moxifloxacin (MOX): Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Results.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S762, doi. 10.1093/ofid/ofz360.1911
- By:
- Publication type:
- Article
LB3. Exebacase (EXE) Reduced Length of Stay and 30-Day Readmission Rates for US Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia Including Endocarditis Compared with Standard of Care Antibiotics (SoC) Alone in a Phase 2 Study.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S994, doi. 10.1093/ofid/ofz415.2486
- By:
- Publication type:
- Article
Omadacycline for Acute Bacterial Skin and Skin Structure Infections.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, p. S23, doi. 10.1093/cid/ciz396
- By:
- Publication type:
- Article
Efficacy and Safety of Tedizolid and Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Injection Drug Users: Analysis of Two Clinical Trials.
- Published in:
- Infectious Diseases & Therapy, 2018, v. 7, n. 4, p. 509, doi. 10.1007/s40121-018-0211-4
- By:
- Publication type:
- Article
Early Clinical Response as a Predictor of Late Treatment Success in Patients With Acute Bacterial Skin and Skin Structure Infections: Retrospective Analysis of 2 Randomized Controlled Trials.
- Published in:
- Clinical Infectious Diseases, 2017, v. 64, n. 2, p. 214, doi. 10.1093/cid/ciw750
- By:
- Publication type:
- Article
SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 8, p. 1007, doi. 10.1093/cid/ciw490
- By:
- Publication type:
- Article
Source Control Review in Clinical Trials of Anti-Infective Agents in Complicated Intra-Abdominal Infections.
- Published in:
- Clinical Infectious Diseases, 2013, v. 56, n. 12, p. 1765, doi. 10.1093/cid/cit128
- By:
- Publication type:
- Article
Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double-Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin-Structure Infection.
- Published in:
- Clinical Infectious Diseases, 2010, v. 51, n. 6, p. 641, doi. 10.1086/655827
- By:
- Publication type:
- Article
LETTERS.
- Published in:
- 2002
- By:
- Publication type:
- Letter
Are weekly courses of antenatal steroids beneficial or dangerous?
- Published in:
- 2002
- By:
- Publication type:
- commentary